Ashley Cunningham, MD

Associate Professor

view physician profile

Locations

Drexel Town Square Health Center

Specialties

Hematopathology

Languages

English

Education

MD - Doctor of Medicine

Biography

Dr. Cunningham’s primary clinical activity is in the Hematopathology service at the Medical College of Wisconsin/Froedtert Hospital and Children’s Wisconsin which covers morphology and flow cytometry sign-out of bone marrow and lymph node biopsies. She is also involved in medical student and pathology resident teaching.

Research Interests

Myeloid Neoplasms

Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology.

(Zorn KE, Cunningham AM, Meyer AE, Carlson KS, Rao S.) Cancers (Basel). 2023 Feb 24;15(5) PMID: 36900239 PMCID: PMC10000481 03/12/2023
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study.

(Dong J, Garacci Z, Buradagunta CS, D'Souza A, Mohan M, Cunningham A, Janz S, Dhakal B, Thrift AP, Hari P.) Blood Cancer J. 2022 Feb 24;12(2):34 PMID: 35210395 PMCID: PMC8873507 SCOPUS ID: 2-s2.0-85125303734 02/26/2022
Diffuse Leptomeningeal Histiocytic Sarcoma: Histologic and Molecular Findings in an Autopsy Case.

(Onyenekwu CP, Cunningham AM, Schilter K, Reddi HV, Cochran EJ.) J Neuropathol Exp Neurol. 2022 Jan 21;81(1):79-81 PMID: 35062029 SCOPUS ID: 2-s2.0-85123746666 01/22/2022
Unexplained Hematocrit Increase after Therapeutic Phlebotomy in a Patient with Marked Erythrocytosis.

(Machhi R, Cunningham AM, Hennrick K, Schaser KA, Williams EC, Rose WN.) Case Rep Hematol. 2022;2022:5018388 PMID: 35990284 PMCID: PMC9388299 08/23/2022
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial.

(Shah NN, Johnson BD, Schneider D, Zhu F, Szabo A, Keever-Taylor CA, Krueger W, Worden AA, Kadan MJ, Yim S, Cunningham A, Hamadani M, Fenske TS, Dropulić B, Orentas R, Hari P.) Nat Med. 2020 Oct;26(10):1569-1575 PMID: 33020647 SCOPUS ID: 2-s2.0-85092105030 10/07/2020
Simple Laboratory Test Utilization Interventions to Reduce Inappropriate Specialty Coagulation Testing.

(Huang H, Cunningham AM, Harrington AM.) Am J Clin Pathol. 2020 Jan 02;153(2):181-189 PMID: 31602457 SCOPUS ID: 2-s2.0-85077403173 10/12/2019
Ancillary Studies in the Diagnostic Evaluation of Large B-Cell Lymphoma.

(Cunningham AM, Harrington AM.) Arch Pathol Lab Med. 2019 Dec;143(12):1464-1471 PMID: 31584842 SCOPUS ID: 2-s2.0-85075813941 10/05/2019
Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.

(Dhakal B, Pagenkopf A, Mushtaq MU, Cunningham AM, Flietner E, Morrow Z, Papadas A, Hope C, Leith C, Hematti P, Hari P, Callander NS, Asimakopoulos F.) Leuk Lymphoma. 2019 Oct;60(10):2558-2562 PMID: 30845856 PMCID: PMC7176050 SCOPUS ID: 2-s2.0-85062788299 03/09/2019
Standardization of transfusion practice in organ donors using the Digital Intern, an electronic decision support algorithm.

(Connor JP, Cunningham AM, Raife T, Rose WN, Medow JE.) Transfusion. 2017 Jun;57(6):1369-1375 PMID: 28266049 03/08/2017
Epidemiology of Bednar tumors in the United States.

(Liszewski W, Blanchette D, Cunningham AM, Miller DD.) J Am Acad Dermatol. 2016 Nov;75(5):1064-1066 PMID: 27745635 10/18/2016
Pathologic Features of Primary Pancreatic Malignancies.

(Cunningham, AM, Rush PS, Matkowskyj KA.) Cancer Treat Res. 2016;168:77-100 PMID: 29206022 01/01/2016
Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.

(Bannas P, Kramer H, Hernando D, Agni R, Cunningham AM, Mandal R, Motosugi U, Sharma SD, Munoz del Rio A, Fernandez L, Reeder SB.) Hepatology. 2015 Nov;62(5):1444-55 PMID: 26224591 PMCID: PMC4652324 08/01/2015